OTC Markets EXMKT - Delayed Quote USD

Levitee Labs Inc. (LVTTF)

Compare
0.0020
+0.0020
(0.00%)
At close: December 27 at 3:00:00 PM EST

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. David Bentil CEO & Director -- -- --
Mr. Marc Momeni Executive VP & Co-Founder -- -- --
Mr. Pouya Farmand Co-Founder -- -- --
Mr. Mackenzie Osborne C.F.A. Head of M&A, Co-Founder and Director -- -- --
Maigul Wickham CPA Chief Financial Officer -- -- --
Dr. Fady Hannah-Shmouni FRCPC, M.D. Chief Medical & Scientific Officer and President of Clinics -- -- --
Olivia Belcher-Coward Marketing & Communications Manager -- -- --
Mr. Azim Qazi M.B.A. Head of Ecommerce & Consumer Packaged Goods -- -- --

Levitee Labs Inc.

800 West Pender Street
Suite 215
Vancouver, BC V6C 1J8
Canada
https://www.leviteelabs.com
Sector: 
Healthcare

Description

Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions. The company operates five clinics under the Levitee Clinics name; and three pharmacies in Alberta under the Levitee Pharmacies name. In addition, it offers electronic-prescriptions in the addiction treatment space under the BlockMD name; and wholesales supplements and superfood under the Earth Circle Organics name. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.

Corporate Governance

Levitee Labs Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.